LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.18 | 84.90 | 915 | 492 | 1.8584 | 1.5536 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.18 | 84.90 | 812 | 492 | 1.6492 | 1.4362 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.88 | 84.90 | 16 | 531 | 0.0301 | -0.4679 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.88 | 84.90 | 965 | 531 | 1.8173 | 1.5068 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.88 | 84.90 | 860 | 531 | 1.6196 | 1.3999 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 14.58 | 84.90 | 284 | 663 | 0.4281 | 0.5025 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 14.58 | 84.90 | 975 | 663 | 1.4697 | 1.2772 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 14.58 | 84.90 | 49 | 663 | 0.0739 | -0.1691 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 14.58 | 84.90 | 929 | 663 | 1.4004 | 1.2404 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.29 | 84.90 | 506 | 766 | 0.6598 | 0.7545 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.29 | 84.90 | 1040 | 766 | 1.3562 | 1.2014 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.29 | 84.90 | 80 | 766 | 0.1043 | -0.0185 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.29 | 84.90 | 957 | 766 | 1.2480 | 1.1445 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.99 | 84.90 | 671 | 898 | 0.7464 | 0.8354 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.99 | 84.90 | 1090 | 898 | 1.2125 | 1.1165 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.99 | 84.90 | 104 | 898 | 0.1157 | 0.0614 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.99 | 84.90 | 902 | 898 | 1.0034 | 1.0020 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 19.69 | 84.90 | 867 | 1239 | 0.6995 | 0.8235 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 19.69 | 84.90 | 1058 | 1239 | 0.8536 | 0.9198 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 19.69 | 84.90 | 368 | 1239 | 0.2969 | 0.4611 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 19.69 | 84.90 | 889 | 1239 | 0.7173 | 0.8353 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.40 | 84.90 | 879 | 1454 | 0.6043 | 0.7687 | MN20160318_Q02 | C04 |